Arkolith/Insider Trading/SANA/Form 4

Mulligan Richard

DirectorSana Biotechnology, Inc. (SANA) · full profile →Form 4 · filed Sep 26, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 25, 2024Sell(S)150K$3.89$584K2.7M
Sep 24, 2024Sell(S)150K$4.08$612K2.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-006954) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML